Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Safety and tolerability of fremanezumab for treating migraine: where are we now? — SciRadar

Back to results

Expert opinion on drug safety

Safety and tolerability of fremanezumab for treating migraine: where are we now?

Carolin Luisa Hoehne, Bianca Raffaelli

Published: 202510.1080/14740338.2025.2601037

No abstract available for this study.